In summary, we show that besides gene mutations in DNA methylation and histone modification, mutations affecting signal transduction, RNA splicing factors, and transcription factors, particularly ETV6 and IKZF1, are frequently present in BPDCN. This evidence concerns the gene ETV6 and CD4+/CD56+ hematodermic neoplasm.